The molecular mechanisms that underlie the primary headaches-migraine, clus
ter headache and tension-type headache-have not yet been clarified. On the
basis of studies in headache induced by intravenous infusions of glyceryl t
rinitrate (an exogenous nitric oxide donor) and histamine (which liberates
nitric oxide from vascular endothelium), it has been suggested that nitric
oxide is a likely candidate responsible molecule. The present review deals
with the biology of this small messenger molecule, and the updated scientif
ic evidence that suggests a key role for this molecule in primary headaches
. This evidence suggests that the release of nitric oxide from blood vessel
s, perivascular nerve endings or from brain tissue is an important molecula
r trigger mechanism in spontaneous headache pain. Pilot trials have shown e
fficacy of a nitric oxide synthase inhibitor in both migraine attacks and c
hronic tension-type headache. These observations suggest new approaches to
the pharmacological treatment of headache. Curr Opin Neurol 14:315-321. (C)
2001 Lippincott Williams & Wilkins.